References
- Zhang SQ, Jiang T, Li M, et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nature Genet 2012;44:1156–1160.
- Roosing S, Collin RW, den Hollander AI, et al. Prenylation defects in inherited retinal diseases. J Med Genet 2014;51:143–151.
- van der Burgh R, Ter Haar NM, Boes ML, et al. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol 2013;147:197–206.
- Esposito S, Ascolese B, Senatore L, et al. Current advances in the understanding and treatment of mevalonate kinase deficiency. Int J Immunopathol Pharmacol 2014;27:491–498.
- Ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever Registry. Arthritis Rheumatol 2016. doi: 10.1002/art.39763 [Epub ahead of print].
- van der Meer JWM, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1984;323:1087–1090.
- Hoffmann GF, Charpentier C, Mayatepek E, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 1993;91:915–921.
- Mandey, SHL, Schneiders MS., Koster J, et al. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 2006;27:796–802.
- Bader-Meunier B, Florkin B, Sibilia J, et al. Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 2011;128:e152–e159
- Levy M, Arion A, Berrebi D, et al. Severe early-onset colitis revealing mevalonate kinase deficiency. Pediatrics 2013;132:e779–e783.
- von Linstow ML, Rosenfeldt V. Neonatal hepatitis as first manifestation of hyperimmunoglobulinemia D syndrome. Case Rep Pediatr 2014;2014:936890.
- Cuisset L, Drenth JPH, Simon A, et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Europ J Hum Genet 2001;9:260–266.
- Zhang Z, Li C, Wu F, et al. Genomic variations of the mevalonate pathway in porokeratosis. eLife 2015;4:e06322.
- Balgobind B, Wicebol-Post D, Frenkel J. Retinitis pigmentosa in mevalonate kinase deficiency. J Inherit Metab Dis 2005;28:1143–1145
- Prietsch V, Mayatepek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 2003;111:258–261.
- Simon A, Kremer HP, Wevers RA, et al. Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 2004;62:994–997.
- Wilker SC, Dagnelie G, Goldberg MF. Retinitis pigmentosa and punctate cataracts in mevalonic aciduria. Retin Cases Brief Rep 2010;4:34–36.
- Siemiatkowska AM, van den Born LI, van Hagen M, et al. Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa. Ophthalmology 2013;120:2697–2705.
- Kellner U, Kellner S, Weber BH, et al. Lipofuscin- and melanin-related fundus autofluorescence visualize different retinal pigment epithelial alterations in patients with retinitis pigmentosa. Eye 2009;23:1349–1359
- Kellner S, Kellner U, Weinitz S. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 2009;93;1444–1447.
- Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975;94:441–448.
- Houten SM, Romeijn GJ, Koster J, et al. Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. Hum Mol Genet 1999;8:1523–1528.
- Hinson DD, Ross RM, Krisans S, et al. Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. Am J Hum Genet 1999;65:327–335.
- Drenth JP, Mariman EC, Van der Velde-Visser SD, et al. Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. International Hyper-IgD Study Group. Hum Genet 1994;94:616–620.
- Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850–858
- Fliesler SJ, Keller RK. Isoprenoid metabolism in the vertebrate retina. Int J Biochem Cell Biol 1997;29:877–894.